BR100 Increased By (0.3%)
BR30 Increased By (0.14%)
KSE100 Increased By (0.09%)
KSE30 Decreased By (-0.04%)
BECO 5.88 Decreased By ▼ -0.15 (-2.49%)
BML 57.70 Increased By ▲ 4.95 (9.38%)
BOP 33.98 Decreased By ▼ -0.27 (-0.79%)
CNERGY 8.16 No Change ▼ 0.00 (0%)
DCL 11.86 Decreased By ▼ -0.48 (-3.89%)
FCCL 53.80 Decreased By ▼ -0.09 (-0.17%)
FCSC 5.31 Increased By ▲ 0.09 (1.72%)
FFL 17.89 Decreased By ▼ -0.14 (-0.78%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.27 Increased By ▲ 0.27 (2.45%)
KEL 8.13 Increased By ▲ 0.02 (0.25%)
KOSM 5.47 Increased By ▲ 0.09 (1.67%)
MLCF 88.29 Increased By ▲ 0.24 (0.27%)
NBP 186.20 Decreased By ▼ -0.28 (-0.15%)
PACE 11.61 Increased By ▲ 0.89 (8.3%)
PAEL 40.56 Increased By ▲ 0.62 (1.55%)
PIAHCLA 26.33 Increased By ▲ 0.16 (0.61%)
PIBTL 17.30 Decreased By ▼ -0.02 (-0.12%)
PPL 231.98 Decreased By ▼ -0.80 (-0.34%)
PRL 34.75 Decreased By ▼ -0.20 (-0.57%)
PTC 67.20 Decreased By ▼ -0.36 (-0.53%)
SEARL 91.40 Increased By ▲ 0.47 (0.52%)
SSGC 27.00 Decreased By ▼ -0.17 (-0.63%)
TELE 8.59 Increased By ▲ 0.02 (0.23%)
THCCL 64.76 Increased By ▲ 4.63 (7.7%)
TPLP 9.40 Increased By ▲ 0.64 (7.31%)
TREET 24.69 Increased By ▲ 0.15 (0.61%)
TRG 72.10 Increased By ▲ 0.35 (0.49%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
Markets

Tokyo stocks open lower as investors hunt leads

  • The Japanese health ministry may approve the drug by the end of this year, the latest local reports said.
Published June 9, 2021 Updated June 9, 2021 11:47am
By

TOKYO: Tokyo stocks opened lower on Wednesday after subdued US trade, as investors sought fresh market-moving events.

The benchmark Nikkei 225 index was down 0.28 percent or 80.89 points at 28,882.67 in early trade, while the broader Topix index slipped 0.12 percent or 2.38 points to 1,960.27.

"The Japanese market is starting in a narrow range following a mixed performance by US stocks," senior market analyst Toshiyuki Kanayama of Monex said in a note.

Wall Street stocks finished a choppy session little changed as markets digested data showing a lower US trade deficit.

Equities have been choppy in recent weeks as investors have assessed the upside of the reopening economy against worries over inflation and supply chain troubles.

This week's calendar includes crucial US consumer price data on Thursday that could either exacerbate or mitigate inflation worries.

The dollar fetched 109.46 yen in early Asian trade, against 109.49 yen in New York late Tuesday.

In Tokyo, pharmaceutical firm Eisai was unpriced in early trade for a second straight day as it was overwhelmed by buy orders after the United States approved the Alzheimer's drug it developed with Biogen, the first new medicine against the disease in almost two decades.

In the previous day's trade, the firm eventually soared 19.35 percent to close at 9,251 yen.

The Japanese health ministry may approve the drug by the end of this year, the latest local reports said.

Among other shares, Sony was down 2.28 percent at 10,750 yen, chip-testing equipment maker Advantest was off 2.49 percent at 9,800 yen, and shipping firm Mitsui O.S.K. Lines was down 1.75 percent at 4,785 yen.

On Wall Street, the Dow finished down 0.1 percent at 34,599.82, the broad-based S&P was flat, and the tech-rich Nasdaq advanced 0.3 percent.

Comments

Comments are closed for this article.